BullFrog AI Holdings, Inc. (BFRG): Cost of Revenue
$94.8K
Year ended 2025-12-31
$176.5K
Trailing 12 months to 2026-06-30
n/m
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $94.8K | n/a | 2026-03-19, From 2025-01-01 |
| No annual figure between 2023-12-31 and 2025-12-31. | |||
| 2023-12-31 | $5.2K | +550.0% | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $800 | n/a | 2024-03-29, From 2022-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $94.8K | n/a |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $44.3K | +658.7% |
| Clene Inc. (CLNN) | 2025-12-31 | $43.0K | -38.6% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $43.4K | -97.3% |
| Abvc Biopharma, Inc. (ABVC) | 2024-12-31 | $763 | -99.7% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $100.9K | +62.9% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $424.0K | n/a |
| Scienture Holdings, Inc. (SCNX) | 2025-12-31 | $100.1K | -23.4% |
| Quantum Cyber N.V. (QUCY) | 2025-12-31 | $147.3K | -53.8% |
Compare BFRG, SILO, CLNN, HCWB side by side · Screen every company in Pharmaceutical Preparations ↗